ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2021 American Transplant Congress

    Does High-Risk CMV Discordance Affect Elderly Kidney Transplant Recipient Survival? A Multivariable Analysis

    A. Dinesh1, S. Jackson2, S. Riad3, T. L. Pruett1

    1Division of Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN, 2Biostatistics, Analytics Consulting Services- Solid Organ Transplant, M Health Fairview, Minneapolis, MN, 3Department of Medicine, University of Minnesota, Minneapolis, MN

    *Purpose: High-risk CMV discordance (R-/D+) has often been linked to deleterious outcomes after kidney transplantation. The elderly transplant population is more susceptible to CMV infections…
  • 2021 American Transplant Congress

    Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure

    H. Mogallapalli

    Department of Medicine, University of Wisconsin-Madison, Madison, WI

    *Purpose: Calcineurin inhibitors (CNI) exert deleterious effect on cardiovascular risk in kidney transplant recipients (KTRs). Belatacept conversion may reduce CV risk in KTRs. We hypothesized…
  • 2021 American Transplant Congress

    Incidentally Detected Malignancies in Lung Explants: Single Center Case Series

    D. Razia, A. Arjuna, L. Schaheen, J. Huang, M. Smith, R. Bremner, R. Walia

    Thoracic Surgery and Lung Transplantation, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ

    *Purpose: Thoracic malignancies are difficult to prospectively diagnose in patients with end-stage lung disease due to complex radiologic features. We present a series of lung…
  • 2021 American Transplant Congress

    Successful Outcomes from Selected Akin3 Donors Requiring Renal Replacement: Avenue for Increase in Organ Utilization

    P. Budhiraja1, R. L. Heilman1, M. L. Smith2, H. A. Khamash1, L. Kodali1, A. A. Moss3, A. K. Mathur3, C. Jadlowiec3, K. S. Reddy3

    1Medicine, Mayo Clinic, Phoenix, AZ, 2Pathology, Mayo Clinic, Phoenix, AZ, 3Surgery, Mayo Clinic, Phoenix, AZ

    *Purpose: Our aim was to determine outcomes with transplanting kidneys from deceased donors with severe acute kidney injury requiring acute renal replacement therapy.*Methods: We included…
  • 2021 American Transplant Congress

    A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

    Y. Caliskan1, H. Yazici2, A. B. Dirim2, E. Aksoy2, S. Safak2, N. Garayeva2, S. Mirioglu2, O. Yegit2, O. A. Oto2, Y. Ozluk3, S. Besisik4, A. Turkmen2, K. Lentine1

    1Saint Louis University, Saint Louis, MO, 2Division of Nephrology, Istanbul University, Istanbul, Turkey, 3Department of Pathology, Istanbul University, Istanbul, Turkey, 4Division of Hematology, Istanbul University, Istanbul, Turkey

    *Purpose: Effective management to prevent allograft loss after late antibody mediated rejection (ABMR) in kidney transplant (KTx) recipients remains a vexing clinical challenge. While plasma…
  • 2021 American Transplant Congress

    Effect of HLA-DR Mismatches on Graft Outcomes of Kidney Transplant from Elderly Donors

    P. Homkrailas, S. Bunnapradist

    David Geffen School of Medicine at UCLA, Los Angeles, CA

    *Purpose: Human leukocyte antigen (HLA)-DR has been shown to be more immunogenic than HLA-A or -B. The impact of HLA-DR mismatches remains unclear among kidney…
  • 2021 American Transplant Congress

    Kidney Transplantation in Patients with Hereditary Kidney Diseases

    Y. Caliskan1, N. Garayeva2, A. B. Dirim2, S. Safak2, S. Mirioglu2, H. Yazici2, A. Yildiz3, O. A. Oto2, E. Demir2, Y. Ozluk4, A. Turkmen2, K. Lentine1

    1Saint Louis University, Saint Louis, MO, 2Division of Nephrology, Istanbul University, Istanbul, Turkey, 3Division of Nephrology, Uludag University, Bursa, Turkey, 4Department of Pathology, Istanbul University, Istanbul, Turkey

    *Purpose: Genetic testing is poised to play a larger role in the evaluation and management of both kidney transplant (KTx) recipients and donors. We characterized…
  • 2021 American Transplant Congress

    Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database

    H. Patel1, N. Agrawal1, R. Gupta1, P. Geetha2, A. Abdul Razzack3, F. Cardarelli1

    1Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 2Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 3Medicine, Dr. NTR University of Health Sciences, Vijaywada, India

    *Purpose: Malignancy is the third major cause of death among transplant recipients. Among the transplant recipients, Patient and kidney transplant outcomes after the diagnosis of…
  • 2021 American Transplant Congress

    Rabbit Anti-thymocyte Globulin Induction is Not Associated with Improved Outcomes in Liver Transplant Recipients

    P. Nguyen, N. Wilson, G. Saracino, R. Patel, S. K. Asrani, G. Testa, T. Sam

    Baylor University Medical Center, Dallas, TX

    *Purpose: Controversy remains on the role of rabbit anti-thymocyte globulin (rATG) induction for calcineurin inhibitor (CNI) delay after liver transplantation (LT). We examined the effect…
  • 2021 American Transplant Congress

    Lymphotoxin Beta Receptor Regulates Treg Migration and Suppression by Modulating Draining Lymphatic Structure

    V. Saxena1, W. Piao1, L. Li1, M. W. Shirkey1, J. Iyyathurai1, R. Lakhan1, R. Abdi2, J. Bromberg1

    1U Maryland, Baltimore, MD, 2Harvard U, Boston, MA

    *Purpose: Regulatory T cells (Treg) must migrate from tissues via lymphatic vessels (LV) to the draining lymph node (dLN) to induce tolerance. During migration, Treg…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences